Research Keyword: wild-type isolates

Establishment of epidemiological cutoff values for Fonsecaea pedrosoi, the primary etiologic agent of chromoblastomycosis, and eight antifungal medications

Chromoblastomycosis is a serious fungal skin infection caused by a fungus called Fonsecaea pedrosoi, particularly affecting people in tropical regions and those in poverty. Researchers from multiple countries tested 148 samples of this fungus against eight different antifungal medications to determine how well each drug works. They established baseline measurements that doctors can use to determine if a patient’s fungal infection might not respond well to standard treatments, helping guide better treatment decisions.

Read More »

Appearance of Environment-Linked Azole Resistance in the Aspergillus fumigatus Complex in New Zealand

Researchers in New Zealand have discovered that a dangerous fungus called Aspergillus fumigatus is developing resistance to commonly used antifungal medications. Unlike previous cases where the resistance came from medical treatment, this new resistance appears to come from environmental exposure, possibly through garden fungicides that people can buy at garden centers. The study found that people, especially lung transplant patients, may be acquiring these resistant fungal strains from their surroundings rather than from hospitals, highlighting the need for better monitoring of agricultural fungicide use.

Read More »
Scroll to Top